Cravens & CO Advisors, LLC Eli Lilly & CO Transaction History
Cravens & CO Advisors, LLC
- $134 Billion
- Q2 2025
A detailed history of Cravens & CO Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cravens & CO Advisors, LLC holds 1,534 shares of LLY stock, worth $1.26 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
1,534Holding current value
$1.26 Million% of portfolio
0.89%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
4,454Shares Held
780MCall Options Held
16.5MPut Options Held
12.2M-
Lilly Endowment Inc Indianapolis, IN96MShares$78.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$65.9 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$54 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$42 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.5MShares$28.3 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $779B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...